Display options
Share it on

Taiwan J Ophthalmol. 2015 Apr-Jun;5(2):99-102. doi: 10.1016/j.tjo.2014.05.007. Epub 2014 Aug 01.

Ocular adnexal lymphoma: Five case reports and a literature review.

Taiwan journal of ophthalmology

Chui-Lien Tsen, Muh-Chiou Lin, Youn-Shen Bee, Jiunn-Liang Chen, Ni-Wen Kuo, Shwu-Jiuan Sheu

Affiliations

  1. Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
  2. School of Medicine, National Yang-Ming University, Taipei, Taiwan.

PMID: 29018677 PMCID: PMC5602737 DOI: 10.1016/j.tjo.2014.05.007

Abstract

This article reports the clinical course and treatment of ocular adnexal lymphoma based on a retrospective review of five cases with a histologically approved ocular adnexal lymphoma at Kaohsiung Veterans General Hospital over 10 years. Extranodal B-cell lymphoma in the orbit, lacrimal gland, eyelid, or conjunctiva was found in these patients. Four of them were female, and they were aged 45-64 years. All patients were also consulted with hematologists for possible systemic involvement and therapeutic plan. The patient with retrobulbar and orbital apex involvement received systemic chemotherapy. The patient with lacrimal gland involvement experienced tumor recurrence after local excision, and therefore received adjuvant radiotherapy. The remaining three patients had localized lymphoma on the eyelid or bulbar conjunctiva, and they all showed no recurrence after surgical excision. The incidence of ocular adnexal lymphoma has risen worldwide over the last few decades. Although most cases are confined to ocular adnexal, some may also be associated with disseminated lymphoma. Accurate diagnosis and staging is mandatory for appropriate treatment. Generally speaking, localized and low-grade ocular adnexal lymphoma involved eyelid or conjunctiva seem to have good outcome after surgical excision only. Systemic chemotherapy should be considered in patients with advanced disease or systemic manifestations, and radiotherapy also offers a good choice for lacrimal gland lymphoma.

Keywords: extranodal B-cell lymphoma; mucosa associated lymphoid tissue lymphoma; ocular adnexal lymphoma; ocular manifestations

Conflict of interest statement

Conflicts of interest: The authors do not have any financial conflicts or interests in the subject matter in the manuscript, and do not have any commercial or propriety interests in any products or co

References

  1. J Clin Oncol. 2006 Mar 20;24(9):1370-5 - PubMed
  2. Blood. 2003 Apr 1;101(7):2489-95 - PubMed
  3. Br J Ophthalmol. 2005 Mar;89(3):352-9 - PubMed
  4. Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):892-8 - PubMed
  5. Graefes Arch Clin Exp Ophthalmol. 2004 Feb;242(2):130-145 - PubMed
  6. J Natl Cancer Inst. 2006 Jul 5;98(13):936-9 - PubMed
  7. Cancer. 2003 Aug 15;98(4):865-71 - PubMed
  8. Br J Ophthalmol. 2000 Aug;84(8):907-13 - PubMed
  9. J Pathol. 2006 Jul;209(3):344-51 - PubMed
  10. Ophthalmology. 2001 Mar;108(3):559-62 - PubMed
  11. Clin Exp Ophthalmol. 2001 Dec;29(6):387-93 - PubMed
  12. Hematol Oncol. 2004 Dec;22(4):143-58 - PubMed
  13. Radiother Oncol. 1996 Jan;38(1):13-8 - PubMed
  14. Cancer. 1983 Oct 15;52(8):1410-6 - PubMed

Publication Types